Transforming growth factor beta 1 serum levels in patients with preinvasive and invasive lesions of the breast

International Journal of Biological Markers

Volumn 19, Issue 3, 2004, Pages 236-239

  Lebrecht, Antje ^a,c   Grimm, C ^b   Euller, G ^b   Ludwig, E ^b   Ulbrich, E ^c   Lantzsch, T ^c   Hefler, L ^b,c   Koelbl, H ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Breast cancer; DCIS; Serum; TGF 1

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BENIGN TUMOR; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DISEASE; BREAST FIBROADENOMA; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CARCINOMA IN SITU; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRECANCER; PREDICTION; PROTEIN BLOOD LEVEL;

EID: 6444229300     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.2143     Document Type: Article

References (15)

1. Bouillier H, Samain E, Miserey S, et al. Transforming growth factor-beta1 modulates angiotensin II-induced calcium release in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 2000; 18: 733-42.
2. Bitzer M, Sterzel RB, Bottinger EP. Transforming growth factor-beta, in renal disease. Kidney Blood Press Res 1998; 21: 1-12.
3. Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M, Lye SJ. Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest 1999; 103: 1641-50.
4. Djurovic S, Schjetlein R, Wisloff F, Haugen G, Husby H, Berg K. Plasma concentrations of Lp(a) lipoprotein and TGF-beta1 are altered in preeclampsia. Clin Genet 1997; 52: 371-6.
5. Donovan J, Slingerland J. Transforming growth factor-beta and breast cancer: Cell cycle arrest by transforming growth factor-beta and is disruption in cancer. Breast Cancer Res 2000; 2: 116-24.
6. Kesari AL, Chellam VG, Mathew BS, Nair MK, Pillai MR. Transforming growth factor beta related to extent of tumor angiogenesis but not apoptosis or proliferation in breast carcinoma. Breast Cancer 1999; 6: 29-36.
7. Wakefield LM, Yang YA, Dukhanina O. Transforming growth factor-beta and breast cancer: Lessons learned from genetically altered mouse models. Breast Cancer Res 2000; 2: 100-6.
8. Reiss M. Transforming growth factor-beta and cancer: a love-hate relationship? Oncol Res 1997; 9: 447-57.
9. McEarchern JA, Kobie JJ, Mack V, et al. Invasion and metastasis of a mammary tumor involves TGF-beta signaling. Int J Cancer 2001; 91: 76-82.
10. Ziv E, Cauley J, Morin PA, Saiz R, Browner WS. Association between the T29→C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: the study of osteoporotic fractures. JAMA 2001; 285: 2859-63.
11. Decensi A, Torrisi R, Fontana V, et al. Correlation between plasma transforming growth factor-beta 1 and second primary breast cancer in a chemoprevention trial. Eur J Cancer 1998; 34: 999-1003.
12. Gorsch SM, Memoli VA, Stukel TA, Gold LI, Arrick BA. Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer. Cancer Res 1992; 52: 6949-52.
13. Li C, Guo B, Wilson PB, et al. Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer. Int J Cancer 2000; 89: 122-6.
14. Lai LC, Erbas H, Meadows KA, Lennard TW, Holly JM. Insulin-like growth factor binding protein-3 in breast cyst fluid: relationships with insulin-like growth factors I and II and transforming growth factor-beta 1 and 2. Cancer Lett 1996; 110: 207-12.
15. Zanardi S, Pensa F, Torrisi R, et al. Presence of immunoassayable transforming growth factor-beta 1 (TGF-beta 1) in breast cyst fluid (BCF): relationship with the intracystic electrolyte and epidermal-growth-factor (EGF) content. Int J Cancer 1994; 59: 725-7.